Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M211,570Revenue (TTM) $M52,286Net Margin (%)13.4Altman Z-Score2.4
Enterprise Value $M235,131EPS (TTM) $1.1Operating Margin %24.9Piotroski F-Score5
P/E(ttm)30.9Beneish M-Score-2.6Pre-tax Margin (%)15.9Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %2.6Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %1.2Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow16.5y-y EBITDA Growth Rate %-16.6ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %3.4PEG25.7ROE % (ttm)10.8Less Shares Outstanding y-yY
Payout Ratio %103Shares Outstanding M6,066ROIC % (ttm)12.5Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEFirst Eagle Investment 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 34.8816%Add 3.98%141,061
PFEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.01%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -0.26%53,724,766
PFEDavid Dreman 2016-03-31 Buy 0.02%$28.56 - $32.28
($30.14)
$ 34.8816%New holding5,820
PFEKeeley Asset Management Corp 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 34.8816%Add 34.41%104,500
PFET Rowe Price Equity Income Fund 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 34.8816%Add 1.42%14,730,900
PFEDodge & Cox 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -58.56%929,604
PFEKen Fisher 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -1.82%31,746,148
PFEMario Gabelli 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -24.04%537,011
PFECharles Brandes 2016-03-31 Reduce-0.05%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -1.83%5,536,325
PFEDavid Tepper 2016-03-31 Add0.05%$28.56 - $32.28
($30.14)
$ 34.8816%Add 4.15%2,512,250
PFEVanguard Health Care Fund 2016-03-31 Reduce-0.1%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -18.09%7,267,526
PFEJohn Paulson 2016-03-31 Add0.17%$28.56 - $32.28
($30.14)
$ 34.8816%Add 117.81%1,378,100
PFENWQ Managers 2016-03-31 Add0.25%$28.56 - $32.28
($30.14)
$ 34.8816%Add 28.00%2,518,601
PFEJoel Greenblatt 2016-03-31 Buy 0.52%$28.56 - $32.28
($30.14)
$ 34.8816%New holding1,577,263
PFEKahn Brothers 2016-03-31 Reduce-0.73%$28.56 - $32.28
($30.14)
$ 34.8816%Reduce -8.11%1,442,543
PFELeon Cooperman 2016-03-31 Sold Out -0.91%$28.56 - $32.28
($30.14)
$ 34.8816%Sold Out0
PFERichard Pzena 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 34.885%Add 0.08%2,161,593
PFEMario Gabelli 2015-12-31 Reduce$31.33 - $35.45
($33.17)
$ 34.885%Reduce -3.16%706,956
PFERuane Cunniff 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 34.885%Add 31.39%14,850
PFEBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.02%$31.33 - $35.45
($33.17)
$ 34.885%Reduce -0.76%53,862,996
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.491.8view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.973.36view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.54.81view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.534.71view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.664.31view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.83.88view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.714.15view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.843.75view
MADDALUNA ANTHONY JExecutive Vice President 2016-05-09Sell8,950$33.754.03view
SUSMAN SALLYExecutive Vice President 2016-05-05Sell76,116$33.754.03view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Gilead Was Smart to Let Medivation Slip Through its Fingers Aug 29 2016 
    Sanofi's Risk Increases on Acquisition Miss Aug 28 2016 
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016 
    Pharmaceuticals are the New Bonds Aug 26 2016 
    Tight Trading on Thursday with Stocks Ending Lower Aug 25 2016 
    Healthcare Drug Pricing a Factor for the Market on Wednesday Aug 24 2016 
    Which Criteria Best Determine the Success of Mergers? Aug 24 2016 
    U.S. Market Indexes Higher on Tuesday Aug 23 2016 
    Pfizer Acquires Medivation Aug 22 2016 
    Is Pfizer on Its Way Up? Aug 21 2016 

    More From Other Websites
    Mylan To Launch Its Own EpiPen Generic Rival At Half Price Aug 29 2016
    Analyst Recommendations for Akorn in 2016 Aug 29 2016
    Gilead Was Smart to Let Medivation Slip Through its Fingers Aug 29 2016
    Five Healthcare Stocks Hedge Funds Like Aug 29 2016
    In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated Aug 29 2016
    Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021 Aug 29 2016
    What’s the Story behind the Pfizer-Medivation Deal? Aug 29 2016
    [$$] Mylan to launch cut-price generic version of EpiPen Aug 29 2016
    Why Pfizer Remains Attractively Valued With Medivation Aug 29 2016
    What Investors Should Know about the Pfizer-Anacor Deal Aug 29 2016
    Glaxo Bets It Can Shake Up HIV Treatment Aug 28 2016
    [$$] Glaxo Bets It Can Shake Up HIV Treatment Aug 28 2016
    Here Are All The Big Biotech Mergers In 2016 Aug 27 2016
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016
    Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win Aug 26 2016
    Will Pfizer Take a Beating After Its Celebrex Settlement? Aug 25 2016
    Elliott Management Reduced Its Holding in Interpublic Group of Companies Aug 25 2016
    Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal Aug 25 2016
    Pfizer Inks a $1.6 Billion Deal with AstraZeneca Aug 25 2016
    Business Highlights Aug 24 2016
    Pfizer on buying spree with AstraZeneca antibiotics deal Aug 24 2016
    AstraZeneca to sell antibiotic pills business to Pfizer Aug 24 2016
    AstraZeneca to sell molecule antibiotics business to Pfizer Aug 24 2016
    What does AstraZeneca plc’s deal with Pfizer mean for shareholders? Aug 24 2016
    AstraZeneca sells part of antibiotics unit to Pfizer Aug 24 2016
    Pfizer to buy antibiotics business from AstraZeneca Aug 24 2016
    Pfizer to buy antibiotics business from AstraZeneca Aug 24 2016
    Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca Aug 24 2016
    AstraZeneca to sell antibiotics business to Pfizer Aug 24 2016
    AstraZeneca sells part of antibiotics unit to Pfizer Aug 23 2016
    Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Aug 23 2016
    Jacobs Awarded Design Contract for Pfizer Global Biotechnology Center in China Aug 23 2016
    Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016 Aug 23 2016
    Asian stocks in summer lull as markets await Yellen speech Aug 22 2016
    Business Highlights Aug 22 2016
    Pfizer boosts cancer drug roster with $14 billion Medivation deal Aug 22 2016
    Pfizer boosts cancer drug roster with $14 billion Medivation deal Aug 22 2016
    Pfizer boosts cancer drug roster with $14 billion Medivation deal Aug 22 2016
    Medivation surges on Pfizer takeover as US markets stay flat Aug 22 2016
    Medivation surges on Pfizer takeover as US markets stay flat Aug 22 2016
    European stocks dip awaiting clear US rate outlook Aug 22 2016
    Pfizer spends $14B on Medivation in cancer fight Aug 22 2016
    Pfizer to acquire Medivation for $14 billion Aug 22 2016
    Wall Street lower as investors react to Pfizer deal Aug 22 2016
    Wall Street opens lower as Pfizer seals Medivation deal Aug 22 2016
    Wall Street opens lower as Pfizer seals Medivation deal Aug 22 2016
    Pfizer To Buy Cancer Drug Firm Medivation For £10bn Aug 22 2016
    Pfizer to buy Medivation in $US14b deal Aug 22 2016
    Pfizer says acquiring Medivation for $14 billion Aug 22 2016
    Pfizer says acquiring Medivation for $14 bn Aug 22 2016
    Global stocks, oil turn lower ahead of Fed meeting Aug 22 2016
    Pfizer To Acquire Medivation Aug 22 2016
    Pfizer will pay about $14 billion to acquire the cancer drug company Medivation Aug 22 2016
    Medivation surges on Pfizer takeover as US markets stay flat Aug 22 2016
    European stocks dip awaiting clear US rate outlook Aug 22 2016
    Pfizer nears agreement to buy Medivation for $14 bn: reports Aug 22 2016
    Pfizer to acquire Medivation for $14 billion Aug 22 2016
    Wall Street lower as investors react to Pfizer deal Aug 21 2016
    Wall Street opens lower as Pfizer seals Medivation deal Aug 21 2016
    Pfizer says acquiring Medivation for $14 billion Aug 21 2016
    Pfizer says acquiring Medivation for $14 bn Aug 21 2016
    Pfizer nears deal to acquire Medivation for close to $14 billion - sources Aug 21 2016
    Pfizer nears agreement to buy Medivation for $14 bn: reports Aug 21 2016
    FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release... Aug 19 2016
    Patent for J&J's Remicade invalidated, cheaper version looms Aug 17 2016
    Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis)... Aug 08 2016
    Pfizer Limited revenue up by 3.4 % for the Quarter ended June 30, 2016 Aug 06 2016
    US industry bodies sue over Obama corporate tax rules Aug 04 2016
    Business groups sue over new U.S. limit on tax-driven foreign buyouts Aug 04 2016
    Business Highlights Aug 02 2016
    Wall Street falls as weak auto sales spur growth jitters Aug 02 2016
    Pfizer beats estimates, but branded drugs disappoint Aug 02 2016
    Pfizer beats Street 2Q forecasts despite big drop in profit Aug 02 2016
    Pfizer earnings top estimates on higher sales Aug 02 2016
    PFIZER REPORTS SECOND-QUARTER 2016 RESULTS Aug 02 2016
    Pfizer earnings top estimates on higher sales Aug 01 2016
    AstraZeneca a takeover target again? CEO not commenting Jul 28 2016
    Teva, Mylan eye Pfizer's Brazil venture, sources say Jul 26 2016
    Germany plans to extend price brake for drugs under statutory insurance Jul 25 2016
    Fresenius, Smiths in two-way race for Pfizer infusion pumps - sources Jun 06 2016
    Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources Jun 06 2016
    GSK's modern HIV drug to be rolled out in Botswana Jun 03 2016
    Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel May 16 2016
    EXCLUSIVE: Pfizer approaches Medivation about potential takeover -sources May 03 2016
    Investors stick with Pfizer CEO after Allergan deal scrapped Apr 07 2016
    Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change Apr 06 2016
    Obama's inversion curbs kill Pfizer's $160 bln Allergan deal Apr 06 2016
    Obama's inversion curbs kill Pfizer's $160 billion Allergan deal Apr 06 2016
    Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says Apr 05 2016
    Delhi High Court grants Pfizer temporary relief on cough syrup ban Mar 14 2016
    Delhi High Court grants Pfizer temporary relief on cough syrup ban Mar 14 2016
    Delhi High Court stays government ban on Pfizer's Corex cough syrup - TV Mar 14 2016
    Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India Mar 11 2016
    Pfizer 2016 forecasts disappoint; shares fall Feb 02 2016
    Pfizer, IIT-Delhi collaborate for healthcare incubation Nov 24 2015
    U.S. politicians slam tax-avoiding Pfizer-Allergan deal Nov 23 2015
    Pfizer to buy Allergan in $160 billion deal Nov 23 2015
    Pfizer to buy Allergan in $160 billion deal Nov 23 2015
    U.S. Republican Trump calls Pfizer deal to move tax base overseas 'disgusting' Nov 23 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)